Dr. Vitte completed his Ph.D. degree in Cellular and Molecular Biology at Université d’Evry-Val d’Essonne, France in 2007. Dr. Vitte also received in 2003 a Master of Science in Molecular Genetics from Université René Descartes, Paris, France and a Master of Science in Biotechnology from Université Paris Sud, France. His research focused on understanding the molecular and cellular basis of Spinal Muscular Atrophy based on new cellular and mouse models in the Molecular Neurogenetics laboratory, INSERM, France. During a postdoctoral position in the Neurology and Experimental Therapeutics laboratory at Hopital Pitié-Salpétrière, INSERM, France, he worked on the pathogenesis of Parkinson’s disease, specifically on the localization of LRRK2 expression and on a mouse model of synucleinopathy carrying Parkin and α-synuclein mutations. In 2009, Dr. Vitte moved to Los Angeles, CA to pursue research in the field of neuro-oncology in the Neural Tumor Research laboratory at the House Research Institute and now in the Department of Head and Neck Surgery at the University of California, Los Angeles. His research focuses on understanding the molecular and cellular mechanisms underlying tumor development in Neurofibromatosis type 2 and Schwannomatosis. He is developing and characterizing cellular and animal models as well as performing pre-clinical research and drug testing for these and related tumor predisposition syndromes.
Dr. Vitte’s research is focused on Tumor predisposition syndromes, Neuro-oncology, Neurodegenerative Diseases, Neuromuscular Diseases, Generation and characterization of mouse and cellular models, Pre-clinical research and drug testing